|
|
 Previous Article | Table of Contents | Next Article 
Modulation of the Apoptotic Response of Human Myeloid Leukemia Cells to a Diphtheria Toxin Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein
Arthur E. Frankel,
Philip D. Hall,
Chris Burbage,
Joseph Vesely,
Mark Willingham,
Kapil Bhalla, and
Robert J. Kreitman
From the Departments of Medicine, Pathology, and Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC; the Department of Medicine, Emory University School of Medicine, Atlanta, GA; and Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing cells. We now report that DT388-GM-CSF induces apoptosis and inhibition of colony formation in semisolid medium in receptor positive cells, and that the induction of apoptosis correlates with GM-CSF-receptor occupancy at low ligand concentrations. Also, the induction of apoptosis correlates with the inhibition of protein synthesis and is inversely related to the amount of intracellular antiapoptotic proteins (Bcl2 and Bc1XL ). Nine myeloid leukemia cells lines and four nonmyeloid leukemia cell lines were incubated with 0.7 nmol/L of 125I-GM-CSF in the presence or absence of excess cold GM-CSF and bound label measured. High affinity receptor numbers varied from 0 to 291 molecules per cell. Cells were incubated with varying concentrations of recombinant fusion toxin for 48 hours and incorporation of 3H-leucine (protein synthesis), segmentation of nuclei after DAPI staining (apoptosis), and colony formation in 0.2% agarose (clonogenicity) were measured. DT388-GM-CSF at 4 × 10-9 mol/L inhibited colony formation 1.5 to 3.0 logs for receptor positive cell lines. Protein synthesis and apoptosis IC50s varied among cell lines from greater than 4 × 10-9 mol/L to 3 × 10-13 mol/L. GM-CSF-receptor occupancy at 0.7 nmol/L GM-CSF-ligand concentration correlated with the protein synthesis IC50 . Similarly, the protein synthesis inhibition and apoptosis induction correlated well, except in cells overexpressing Bcl2 and BclXL , in which 25- to 150-fold inhibition of apoptosis was observed. We conclude that DT388-GM-CSF can kill acute myeloid leukemia blasts but that apoptotic sensitivities will depend on the presence of at least 100 high affinity GM-CSF receptors/cell and the absence of overexpressed antiapoptotic proteins.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3654-3661
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. E. Hogge, L. Yalcintepe, S.-H. Wong, B. Gerhard, and A. E. Frankel
Variant Diphtheria Toxin-Interleukin-3 Fusion Proteins with Increased Receptor Affinity Have Enhanced Cytotoxicity against Acute Myeloid Leukemia Progenitors
Clin. Cancer Res.,
February 15, 2006;
12(4):
1284 - 1291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Thorburn, A. E. Frankel, and A. Thorburn
Apoptosis by Leukemia Cell-targeted Diphtheria Toxin Occurs via Receptor-independent Activation of Fas-associated Death Domain Protein
Clin. Cancer Res.,
February 1, 2003;
9(2):
861 - 865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Frankel, B. L. Powell, P. D. Hall, L. D. Case, and R. J. Kreitman
Phase I Trial of a Novel Diphtheria Toxin/Granulocyte Macrophage Colony-stimulating Factor Fusion Protein (DT388GMCSF) for Refractory or Relapsed Acute Myeloid Leukemia
Clin. Cancer Res.,
May 1, 2002;
8(5):
1004 - 1013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Feuring-Buske, A. E. Frankel, R. L. Alexander, B. Gerhard, and D. E. Hogge
A Diphtheria Toxin-Interleukin 3 Fusion Protein Is Cytotoxic to Primitive Acute Myeloid Leukemia Progenitors But Spares Normal Progenitors
Cancer Res.,
March 1, 2002;
62(6):
1730 - 1736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Arceci, B. J. Longley, and P. D. Emanuel
Atypical Cellular Disorders
Hematology,
January 1, 2002;
2002(1):
297 - 314.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Senchenkov, T.-Y. Han, H. Wang, A. E. Frankel, T. J. Kottke, S. H. Kaufmann, and M. C. Cabot
Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF
Blood,
September 15, 2001;
98(6):
1927 - 1934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Frankel, J. Ramage, M. Kiser, R. Alexander, G. Kucera, and M. S. Miller
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
Protein Eng. Des. Sel.,
August 1, 2000;
13(8):
575 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Emanuel, R. C. Snyder, T. Wiley, B. Gopurala, and R. P. Castleberry
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors
Blood,
January 15, 2000;
95(2):
639 - 645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Vallera, S.-Y. Seo, A. Panoskaltsis-Mortari, J. D. Griffin, and B. R. Blazar
Targeting myeloid leukemia with a DT390-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice
Protein Eng. Des. Sel.,
September 1, 1999;
12(9):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Vinante, A. Rigo, E. Papini, M. A. Cassatella, and G. Pizzolo
Heparin-Binding Epidermal Growth Factor-Like Growth Factor/Diphtheria Toxin Receptor Expression by Acute Myeloid Leukemia Cells
Blood,
March 1, 1999;
93(5):
1715 - 1723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Frankel, M. Lilly, R. Kreitman, D. Hogge, M. Beran, M. H. Freedman, P. D. Emanuel, C. McLain, P. Hall, E. Tagge, et al.
Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Is Toxic to Blasts From Patients With Juvenile Myelomonocytic Leukemia and Chronic Myelomonocytic Leukemia
Blood,
December 1, 1998;
92(11):
4279 - 4286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Hogge, C. L. Willman, R. J. Kreitman, M. Berger, P. D. Hall, K. J. Kopecky, C. McLain, E. P. Tagge, C. J. Eaves, and A. E. Frankel
Malignant Progenitors From Patients With Acute Myelogenous Leukemia Are Sensitive to a Diphtheria Toxin-Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein
Blood,
July 15, 1998;
92(2):
589 - 595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
